CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 235.5 SEK -1.46%
Market Cap: 5.6B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Research & Development Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Research & Development
-kr83.3m
CAGR 3-Years
-48%
CAGR 5-Years
-12%
CAGR 10-Years
-18%
Elekta AB (publ)
STO:EKTA B
Research & Development
-kr830m
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Research & Development
-kr180.9m
CAGR 3-Years
-104%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Research & Development
-kr1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Research & Development
-kr149m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CellaVision AB's Research & Development?
Research & Development
-83.3m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Research & Development amounts to -83.3m SEK.

What is CellaVision AB's Research & Development growth rate?
Research & Development CAGR 10Y
-18%

Over the last year, the Research & Development growth was 8%. The average annual Research & Development growth rates for CellaVision AB have been -48% over the past three years , -12% over the past five years , and -18% over the past ten years .

Back to Top